Genome Science and Personalized Cancer Treatment (LBNL Summer Lecture Series)
Abstract
August 4, 2009 Berkeley Lab Summer Lecture Series: Results from the Human Genome Project are enabling scientists to understand how individual cancers form and progress. This information, when combined with newly developed drugs, can optimize the treatment of individual cancers. Joe Gray, director of Berkeley Labs Life Sciences Division and Associate Laboratory Director for Life and Environmental Sciences, will focus on this approach, its promise, and its current roadblocks — particularly with regard to breast cancer.
- Authors:
- Publication Date:
- Research Org.:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC)
- OSTI Identifier:
- 987622
- DOE Contract Number:
- AC02-05CH11231
- Resource Type:
- Multimedia
- Resource Relation:
- Conference: Summer Lecture Series, Lawrence Berkeley National Laboratory, Berkeley, California (United States), presented on August 04, 2009
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES; LBNL; HUMAN GENOME PROJECT; CANCER GENOME ATLAS PROJECT; CANCER; MOLECULAR ABNORMALITIES; TARGETED DRUGS
Citation Formats
Gray, Joe. Genome Science and Personalized Cancer Treatment (LBNL Summer Lecture Series). United States: N. p., 2009.
Web.
Gray, Joe. Genome Science and Personalized Cancer Treatment (LBNL Summer Lecture Series). United States.
Gray, Joe. Fri .
"Genome Science and Personalized Cancer Treatment (LBNL Summer Lecture Series)". United States. https://www.osti.gov/servlets/purl/987622.
@article{osti_987622,
title = {Genome Science and Personalized Cancer Treatment (LBNL Summer Lecture Series)},
author = {Gray, Joe},
abstractNote = {August 4, 2009 Berkeley Lab Summer Lecture Series: Results from the Human Genome Project are enabling scientists to understand how individual cancers form and progress. This information, when combined with newly developed drugs, can optimize the treatment of individual cancers. Joe Gray, director of Berkeley Labs Life Sciences Division and Associate Laboratory Director for Life and Environmental Sciences, will focus on this approach, its promise, and its current roadblocks — particularly with regard to breast cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Fri Aug 07 00:00:00 EDT 2009},
month = {Fri Aug 07 00:00:00 EDT 2009}
}